Envestnet Asset Management »

Revolution Medicines shares owned by Envestnet Asset Management

Quarter-by-quarter ownership of Revolution Medicines (RVMD) shares owned by Envestnet Asset Management from 13F filings

Historical chart of Envestnet Asset Management investment in Revolution Medicines

Tip: Access up to 7 years of quarterly data

All positions including Revolution Medicines held by Envestnet Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revolution Medicines by Envestnet Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $426k 9.4k 45.35

More positions owned by Envestnet Asset Management

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Total Usd (IUSB)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr S&p 500 Grwt Etf (IVW)
Microsoft Corporation (MSFT)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Vanguard Index Fds Value Etf (VTV)
Blackrock Etf Trust Us Eqt Factor (DYNF)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Eafe Value Etf (EFV)
Ishares Tr Core Msci Eafe (IEFA)
Apple (AAPL)

View all positions for Envestnet Asset Management

Top funds holding Revolution Medicines

Vanguard Group
BlackRock
BlackRock
Farallon Capital Management
Baker Bros. Advisors
Nextech Invest
Paradigm Biocapital Advisors
T. Rowe Price Associates
State Street Corporation
Bellevue Group
Henderson Group
Boxer Capital
Alphabet
Jpmorgan Chase & Co
Casdin Capital

View all funds holding Revolution Medicines